Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma - Chesney, J; Puzanov, I; Collichio, F (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018)
et al.